| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 07/06/2005 | EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/06/2005 | EP1550462A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549651A1 Kinase inhibitors |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549627A1 1-phenylalkyl-piperazines |
| 07/06/2005 | EP1549343A2 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
| 07/06/2005 | CN1635874A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/06/2005 | CN1635074A Kidney tonic hygienic wine and its preparation |
| 07/06/2005 | CN1634493A Chinese traditional medicine Tripterygium wilfordii and improving technique for attenuation and synergy of its extract |
| 07/06/2005 | CN1634441A Preparation for improving bioavailability and effect of golden pheasant and preparation method and purpose thereof |
| 07/06/2005 | CN1634428A Ginkgo leaf soft capsule and preparation technique thereof |
| 07/06/2005 | CN1634413A Bastard speedwell injection and preparation method thereof |
| 07/06/2005 | CN1634399A Chinese traditional preparation for treating prostatitis |
| 07/06/2005 | CN1634368A Chinese herbal medicine composition for treating nephritis |
| 07/06/2005 | CN1634363A Five ingredients kaladana containing capsule and preparation technique thereof |
| 07/06/2005 | CN1634350A Medicinal composition for treating nephropathy |
| 07/06/2005 | CN1634338A Medicinal composition for preventing and treating hyperplasia of prostate and preparation method thereof |
| 07/06/2005 | CN1634332A Chinese traditional medicine composition for treating cystitis and urethritis and preparation method thereof |
| 07/06/2005 | CN1634328A Chinese traditional medicine composition for treating diabetic nephropathy |
| 07/06/2005 | CN1634301A Medicine for treating nephropathy |
| 07/06/2005 | CN1634297A Bio-fermentation technique for composite vegetable drug and vegetable fermented drug for treating nephritis |
| 07/06/2005 | CN1634260A Novel method for preparing 'Bazheng Tablet' |
| 07/06/2005 | CN1634218A Enuresis treating Chinese medicinal formulation |
| 07/06/2005 | CN1634196A Kidney tonifying capsule |
| 07/06/2005 | CN1634126A Medicine of polysaccharide sulfate amino acid salt, its preparation and application |
| 07/06/2005 | CN1634114A Clindamycin phosphate orally disintegrating tablet |
| 07/06/2005 | CN1634075A Lycopene and coenzyme Q#-[10] containing formulation and its manufacturing method |
| 07/06/2005 | CN1634066A Dispersible tablet of alfuzosin hydrochloride |
| 07/06/2005 | CN1634032A Andrographolide preparation and its production method |
| 07/06/2005 | CN1634015A Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 07/06/2005 | CN1633999A Allicin microcapsule and its preparation method |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209153C Chinese medicine powder for treating infectious acute kidney failure |
| 07/06/2005 | CN1209114C Use of N-acetyl-D-aminoglucose in preparation of skin membrane mucosa microecologica balance regulator medicine |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914064 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6913926 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner |
| 07/05/2005 | US6913915 PEG-modified uricase |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913750 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 07/05/2005 | US6913744 Administering collagenase and other enzymes; side effect reduction |
| 07/05/2005 | CA2264250C Tablet with controlled release of alfuzosin hydrochloride |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | WO2003018611A3 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 06/30/2005 | US20050143569 Polynucleotides, host cell expression systems, the encoded proteins, polypeptides and peptides |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143453 Selective preventing and therapeutic agents for progressive lesion after organic damage |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143437 Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143357 Vitamin d upregulated protein 1 (vdup-) methods and uses thereof |
| 06/30/2005 | US20050143304 Osteogenic protein/bone morphogenetic proteins of eukaryotic origin |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142625 monoclonal antibodies or antigen-binding fragments having specific binding affinity to an epitope of protein kinases polypeptides, used for the diagnosis and treatment of various kinase-related diseases in humans |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders |
| 06/30/2005 | CA2582611A1 Method of treating elevated plasma homocysteine levels in esrd patients |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/29/2005 | EP1548015A1 Novel crystals |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1547605A1 Adsorbents for oral administration |
| 06/29/2005 | EP1547589A1 Pasting agent |
| 06/29/2005 | EP1547587A1 Agent for reducing side effects of diclofenac |
| 06/29/2005 | EP1547586A1 Hypogastric and/or perineal pain-relieving agent |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546099A2 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546098A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546086A2 Aminoalcohol derivatives |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1545541A1 Use of a quinazoline derivative for treating lower urinary tract symptoms |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545522A1 Use of vanilloid receptor antagonists for the treatment of pain |
| 06/29/2005 | EP1545490A1 Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1242069B1 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/29/2005 | CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |